Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein and Uses Thereof
Technology
E-132-2021
Patent ID
E-132-2021-0-US-01_82723
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/296,380
IC
NIAID
Date Filed
Date Issued
Patent PDF